Autolus Therapeutics PLC expected to post a loss of 48  cents a share - Earnings Preview

Autolus Therapeutics

03/05/2022 19:33

* Autolus Therapeutics PLC  AUTL.OQ   AUTL.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 5. 
    * The London United Kingdom-based   company is expected to
report 
a 5.2% increase in revenue to $282.86 thousand from $269
thousand a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Autolus
Therapeutics PLC
is for a loss of 48 cents per share. For the same quarter last
year, the company reported a loss of 52 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $13​, above​ its last closing price
of $3.24. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.53       -0.46      -0.51     Missed  -10.5
 Sep. 30 2021  -0.52       -0.51      -0.47     Beat    7
 Jun. 30 2021  -0.50       -0.50      -0.47     Beat    5.8​
 Mar. 31 2021  -0.61       -0.60      -0.52     Beat    14
 ​​Dec.        -0.78       -0.77      -0.83     Missed  -8.4
 31 2020                                                
 Sep. 30 2020  -0.70       -0.71      -0.72     Missed  -1.9​
 Jun. 30 2020  -0.70       -0.71      -0.62     Beat    12.5
 Mar. 31 2020  -0.76       -0.74      -0.60     Beat    19.1
 This summary was machine generated May 3 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated